Abstract

Zonula occludens-1 (ZO-1) is involved in the regulation of cell-cell junctions between endothelial cells (ECs). Here we identify the ZO-1 protein interactome and uncover ZO-1 interactions with RNA-binding proteins that are part of stress granules (SGs). Downregulation of ZO-1 increased SG formation in response to stress and protected ECs from cellular insults. The ZO-1 interactome uncovered an association between ZO-1 and Y-box binding protein 1 (YB-1), a constituent of SGs. Arsenite treatment of ECs decreased the interaction between ZO-1 and YB-1, and drove SG assembly. YB-1 expression is essential for SG formation and for the cytoprotective effects induced by ZO-1 downregulation. In the developing retinal vascular plexus of newborn mice, ECs at the front of growing vessels express less ZO-1 but display more YB-1-positive granules than ECs located in the vascular plexus. Endothelial-specific deletion of ZO-1 in mice at post-natal day 7 markedly increased the presence of YB-1-positive granules in ECs of retinal blood vessels, altered tip EC morphology and vascular patterning, resulting in aberrant endothelial proliferation, and arrest in the expansion of the retinal vasculature. Our findings suggest that, through its interaction with YB-1, ZO-1 controls SG formation and the response of ECs to stress during angiogenesis.

ZO-1, a cell junction protein, is essential for angiogenesis. Here the authors identify in endothelial cells unexpected associations of ZO-1 with stress granule proteins, such as YB-1, that are crucial for cytoprotection, implicating the ZO-1-YB-1 interaction in angiogenesis.

Details

Title
ZO-1 interacts with YB-1 in endothelial cells to regulate stress granule formation during angiogenesis
Author
El Bakkouri, Yassine 1   VIAFID ORCID Logo  ; Chidiac, Rony 2   VIAFID ORCID Logo  ; Delisle, Chantal 1 ; Corriveau, Jeanne 1 ; Cagnone, Gael 3   VIAFID ORCID Logo  ; Gaonac’h-Lovejoy, Vanda 1 ; Chin, Ashley 4 ; Lécuyer, Éric 5 ; Angers, Stephane 6   VIAFID ORCID Logo  ; Joyal, Jean-Sébastien 7 ; Topisirovic, Ivan 8   VIAFID ORCID Logo  ; Hulea, Laura 9   VIAFID ORCID Logo  ; Dubrac, Alexandre 10   VIAFID ORCID Logo  ; Gratton, Jean-Philippe 11   VIAFID ORCID Logo 

 Université de Montréal, Department of Pharmacology and Physiology, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
 Université de Montréal, Department of Pharmacology and Physiology, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); University of Toronto, Donnelly Centre, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Canada (GRID:grid.411418.9) (ISNI:0000 0001 2173 6322) 
 Institut de recherches cliniques de Montréal (IRCM), Montreal, Canada (GRID:grid.511547.3) 
 Institut de recherches cliniques de Montréal (IRCM), Montreal, Canada (GRID:grid.511547.3); Université de Montréal, Department of Biochemistry and Molecular Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
 University of Toronto, Donnelly Centre, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Canada (GRID:grid.411418.9) (ISNI:0000 0001 2173 6322); Université de Montréal, Department of Pediatrics, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
 McGill University, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada and Gerald Bronfman Department of Oncology, Faculty of Medicine, Montreal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649) 
 Université de Montréal, Department of Biochemistry and Molecular Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); Université de Montréal, Maisonneuve-Rosemont Hospital Research Centre, Montréal, Quebec, Canada and Department of Medicine, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
10  Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Canada (GRID:grid.411418.9) (ISNI:0000 0001 2173 6322); Université de Montréal, Department of Pathology and Cell Biology, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
11  Université de Montréal, Department of Pharmacology and Physiology, Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136); Université de Montréal, Centre d’Innovation Biomédicale (CIB), Faculty of Medicine, Montreal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2104 2136) 
Pages
4405
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3059116424
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.